Atlas Trials

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Clinical trial NCT00219765 · TERMINATED

Trial details

NCT number
NCT00219765
Sponsor
Poitiers University Hospital
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2001-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.